Try our Advanced Search for more refined results

Intercept Drug Gets Black-Box Warning After Dosing Deaths

By Rachel Graf (February 1, 2018, 4:34 PM EST) -- The U.S. Food and Drug Administration said Thursday it is adding a black-box warning to Intercept Pharmaceuticals Inc.'s liver disease treatment Ocaliva in an effort to prevent incorrect daily dosing instead of weekly dosing in certain patients, which has increased their risk of serious liver injury and death....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!